NCT06763380

Brief Summary

The leading issue that every couple is experiencing in present era is infertility and it has become the major problem worldwide. Many hormonal disorders, weight, diet, and uterine abnormalities contributes in infertility.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

4 months

First QC Date

December 17, 2024

Last Update Submit

January 6, 2025

Conditions

Uterine Abnormality

Outcome Measures

Primary Outcomes (2)

  • 2D Ultrasound Scan

    Uterine anomalies can be diagnosed on routine two-dimensional ultrasound scan

    12 Months

  • Hysterosalpingography test

    HSG is an x-ray exam of the uterus and fallopian tubes. It uses a special form of x-ray called fluoroscopy and a contrast materia.

    12 Months

Interventions

UltrasoundDIAGNOSTIC_TEST

Detection of uterine abnormalities in patients who are infertile buy using Ultrasound

ultrasound then hysterosalpingographyDIAGNOSTIC_TEST

If uterine abnormality could not diagnosed with ultrasound then hysterosalpingography would be performed

Eligibility Criteria

Age20 Years - 37 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsInfertility
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

primary and secondary infertile women using Ultrasound and Hysterosalpingography in Evaluation of Uterine Abnormality

You may qualify if:

  • primary and secondary infertile women

You may not qualify if:

  • Pregnant women. Women with PID

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Essa Lab, High Q tower, Jail Road Lahore"

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Uterine Anomalies

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 17, 2024

First Posted

January 8, 2025

Study Start

February 28, 2024

Primary Completion

July 1, 2024

Study Completion

March 1, 2025

Last Updated

January 8, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations

PA(1)